| |
 |
Cardiovascular Disease Risk of Type 2 Diabetes Mellitus and Metabolic Syndrome: Focus on Aggressive Management of Dyslipidemia
|
| |
|
pp.127-135 (9) Authors: James M. Falko, Robert J. Moser, Sophia B. Meis, Teresa Caulin-Glaser
|
| |
|
|
| |
|
The Metabolic Syndrome and Cardiovascular Risk
|
| |
|
pp.137-143 (7) Authors: Gang Hu, Qing Qiao, Jaakko Tuomilehto
|
| |
|
|
| |
|
Management of the Metabolic Syndrome as a Strategy for Preventing the Macrovascular Complications of Type 2 Diabetes: Controversial Issues
|
| |
|
pp.145-158 (14) Authors: Carlos A. Aguilar-Salinas, Roopa Mehta, Rosalba Rojas, Francisco J. Gomez-Perez, Gustavo Olaiz, Juan A. Rull
|
| |
|
|
| |
|
Platelet in Progression of Atherosclerosis: A Potential Target in Diabetic Patients
|
| |
|
pp.159-165 (7) Authors: Hidenori Koyama, Yoshiki Nishizawa
|
| |
|
|
| |
|
Molecular Mechanisms of Skeletal Muscle Insulin Resistance in Type 2 Diabetes
|
| |
|
pp.167-174 (8) Authors: Karim Bouzakri, Heikki A. Koistinen, Juleen R. Zierath
|
| |
|
|
| |
|
PGC-1α and Exercise: Important Partners in Combating Insulin Resistance
|
| |
|
pp.175-181 (7) Author: Aaron P. Russell
|
| |
|
|
| |
|
Down-Regulation of Angiogenic Inhibitors: A Potential Pathogenic Mechanism for Diabetic Complications
|
| |
|
pp.183-196 (14) Authors: Jian-xing Ma, Sarah X. Zhang, Joshua J. Wang
|
| |
|
|
| |
|
Angiotensin II-Induced Signaling Pathways in Diabetes
|
| |
|
pp.197-202 (6) Authors: Mario B. Marrero, David Fulton, David Stepp, David M. Stern
|
| |
|
|
| |
|
Gestational Diabetes Mellitus: A Review from 2004
|
| |
|
pp.203-213 (11) Author: Richard X. Davey
|
| |
|
|
| |
|
Basal Bolus Dosing: A Clinical Experience
|
| |
|
pp.215-220 (6) Authors: Allen B. King, Dana U. Armstrong
|
| |
|
|
